But they’re not sure what causes general multiple sclerosis or the tumefactive form. ... the doctor will take out a small piece of the growth and look at it under a microscope.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

In-vivo corneal confocal microscopy (IVCM): A promising tool for predicting disease course in persons with multiple sclerosis (MS). Presented at: Women in Ophthalmology Summer Symposium; Aug. 22 ...

The National Multiple Sclerosis Society calls ocrelizumab a "game changer." ... Treatments under the microscope include: An antihistamine (a type of drug often used for allergies) ...

The molecular mechanisms underlying myelin sheath destruction in multiple sclerosis lesions remain unresolved. With immunogold–labeled peptides of myelin antigens and high–resolution ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...